期刊文献+

富血小板血浆与透明质酸钠关节腔内注射治疗膝骨关节炎的疗效比较 被引量:24

Comparison of therapeutic effects of platelet-rich plasma and hyaluronic acid intra-articular injection in the treatment of knee osteoarthritis
原文传递
导出
摘要 目的比较自体富血小板血浆(PRP)与透明质酸(HA)钠关节腔内注射治疗膝骨关节炎的临床效果。方法 2011年10月至2013年11月,盐城市第一人民医院门诊205例(278膝)膝关节炎患者纳入了本研究,根据患者选择进行分组,186例(230膝)完成治疗及随访,HA组82例96膝、PRP组104例124膝,二组分别采用药物2 m L HA钠、3 m L自体PRP加4 m L 5%利多卡因关节腔注射,每周1次,共3次。治疗前和治疗后3、6、12个月对患者进行随访并进行安大略西部和麦克马斯特大学骨关节炎指数(WOMAC)评分评估,对膝关节肿胀消退情况进行观察。两组间各时相点WOMAC评分比较采用t检验,组内不同时间点比较采用重复测量方差分析,组内不同时间点两两比较采用Bonferroni检验。结果 PRP组和HA组患者治疗后WOMAC评分均得到显著改善(F=206.430、122.984,P<0.05)。治疗后3个月,两组间WOMAC评分比较差异无统计学意义(t=-0.046,P>0.05),治疗后6个月和治疗后12个月,PRP组WOMAC评分[(21.43±4.92)分、(21.57±7.32)分]与HA组[(23.44±5.41)分、(29.12±8.27)分]比较,差异有统计学意义(t=-2.519、-5.768,P<0.05)。HA组与PRP组膝关节肿胀治疗后消退情况分别为22膝(31.4%)与41膝(56.9%),两组比较差异有统计学意义(χ2=9.362,P<0.05)。结论 PRP关节腔注射治疗膝骨关节炎获得了更持久的症状缓解效果,更多患者膝关节肿胀消退。 Objective To compare the efficacy of Platelet Rich Plasma (PRP)and Hyaluronic Acid (HA)intra-articular injection in patients with knee osteoarthritis.Methods All 205 patients with knee osteoarthritis in Yancheng City No.1 People′s Hospital were enrolled,which were assigned to the PRP and HA group based on patients′voluntary choice and random principle.Eighty two cases 96 knees in HA group and 104 cases 124 knees in PRP group have got the complete follow-up.Both the two groups were added with 4 mL of 5% lidocaine for intra-articular injection.All patients were prospectively evaluated before and at 3,6,and 12 months after the treatment by WOMAC scores.The patients′knee swelling subsided was observed.Between the two groups WOMAC scores were compared using t test at each time point,within groups were compared using repeated measures analysis of variance,at different time points were compared with Bonferroni test.The knee swelling subside were measured over time.Results No serious adverse events were detected in both groups. At the follow-up evaluations, both groups presented a clinical improvement (F=206.430,122.984,P〈0.05 ).The comparison between the two groups showed a not statistically significant difference 3 months after treatment (t =-0.046,P 〉0.05 ).Six months and 12 months after treatment,PRP group [(21.43 ±4.92),(21.57 ±7.32)points]and HA group [(23.44 ±5.41),(29.12 ±8.27)points]WOMAC score,the difference was statistically significant(t=-2.519 、-5.768,P〈0.05).HA group and PRP group ofter treatment of knee joint swelling subsided were 22 knees (31.4%)and 41 knees (56.95%),there was significant difference between the two groups (χ2 =9.362,P〈0.05).Conclusions PRP intra-articular injection in the treatment of knee osteoarthritis was more durable compared to HA.The more patients′knee swelling was subsided in PRP group.
出处 《中华损伤与修复杂志(电子版)》 CAS 2014年第6期38-41,共4页 Chinese Journal of Injury Repair and Wound Healing(Electronic Edition)
基金 国家自然科学基金青年科学基金项目(81000811)
关键词 膝关节 骨关节炎 富血小板血浆 透明质酸 Knee joint Osteoarthritis, knee Platelet- rich plasma Hyaluronic acid
  • 相关文献

参考文献21

  • 1Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis [J]. Clin Geriatr Med, 2010, 26 (3) : 371-386.
  • 2Nakazawa F, Matsuno H, Yudoh K, et al. Corticosteroid treatment induces chondrocyte apeptosis in an experimental arthritis model and in chondrecyte cultures [J]. Clin Exp Rheumatol, 2002, 20(6) : 773-781.
  • 3Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis [J]. N Engl J Med, 2006, 354(8) : 795-808.
  • 4Brown GA. AAOS clinical practice guideline : treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition [J]. J Am Acad Orthop Surg, 2013, 21(9) : 577-579.
  • 5Bannuro RR, Natov NS, Dasi UR, et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis: meta-analysis. Osteoarthritis Cartilage [J]. 2011, 19(6) : 611-619.
  • 6Petrella RJ, Petrella M. A prospective, randomized, double- blind, placebo controlled study to evaluate the efficacy of intra-articular hyalnranic acid for osteoarthritis of the knee [ J]. J Rheumatol,2006, 33(5) : 951-956.
  • 7Salk RS, Chang TJ, D'Costa WF, et al. Sodium hyaluronate in the treatment of ostcoarthritis of the ankle: a controlled, randomized, double- blind pilot study [J]. J Bone Joint Surg Am, 2006, 88(2) : 295-302.
  • 8Kon E, Filardo G, Di Martino A, et al. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use[J]. Knee Surg Sports Traumatol Arthmsc, 2011, 19(4) : 516-527.
  • 9Gobbi A, Bathan L. Biological approaches for cartilage repair [J]. J Knee Surg, 2009, 22(1) : 36-44.
  • 10邹国友,贾伟涛,郑闽前,朱如里,刘红兵,周仪,徐进,吴亚.自体富含血小板血浆关节腔内注射治疗膝骨性关节炎的初步研究[J].中华损伤与修复杂志(电子版),2013,8(5):25-29. 被引量:14

二级参考文献25

  • 1Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 2Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
  • 3Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
  • 4Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
  • 5Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
  • 6Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388.
  • 7Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669.
  • 8Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944.
  • 9Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2005, 64: 669-681.
  • 10Chevalier X, Marre JP, de Butler J, et al. Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations. Clin Exp Rheumatol, 2004, 22: 205-212.

共引文献1965

同被引文献250

引证文献24

二级引证文献249

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部